3
Registered trials
1
Recruiting
3
Unique sponsors
4
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
C
Cardiology (ATC C)
1
Mechanism of action (INN-stem analysis)
ARB
2 substances
Calcium channel blocker
1 substance
Unknown / small molecule
1 substance
Phase IV:
1
Other:
2
Phase IV
1 trial-
RecruitingStichting Radboud University Medical Center AcademicAMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL; OLMESARTAN MEDOXOMIL, AMLODIPINE
Other
2 trials-
EndedPharma Start LLC CommercialIMP not specified
-
EndedZaklady Farmaceutyczne Polpharma S.A. CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Pharma Start LLC | Commercial | 1 | Other | 0 |
| Zaklady Farmaceutyczne Polpharma S.A. | Commercial | 1 | Other | 0 |
| Stichting Radboud University Medical Center | Academic | 1 | Phase IV | 1 |
New trials by year
2024
2
2025
1